{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T19:50:02Z","timestamp":1772999402217,"version":"3.50.1"},"reference-count":47,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2007,6,1]],"date-time":"2007-06-01T00:00:00Z","timestamp":1180656000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2007,6]]},"DOI":"10.1016\/j.clim.2007.03.004","type":"journal-article","created":{"date-parts":[[2007,4,21]],"date-time":"2007-04-21T11:10:29Z","timestamp":1177153829000},"page":"311-323","source":"Crossref","is-referenced-by-count":51,"title":["In vitro, ex vivo and in vivo immunopharmacological activities of the isoxazoline compound VGX-1027: Modulation of cytokine synthesis and prevention of both organ-specific and systemic autoimmune diseases in murine models"],"prefix":"10.1016","volume":"123","author":[{"given":"Ivana","family":"Stojanovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Cuzzocrea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katia","family":"Mangano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emanuela","family":"Mazzon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djordje","family":"Miljkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mingjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Donia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yousef","family":"Al Abed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ferdinando","family":"Nicoletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stanislava","family":"Stosic-Grujicic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mogens","family":"Claesson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2007.03.004_bib1","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.autrev.2005.04.005","article-title":"CD4+ regulatory T cells: mechanisms of induction and effector function","volume":"4","author":"Bacchetta","year":"2005","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2007.03.004_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1159\/000087104","article-title":"Cytokine dysregulation, inflammation and well-being","volume":"12","author":"Elenkov","year":"2005","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.clim.2007.03.004_bib3","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.2174\/0929867054039044","article-title":"Advances in the treatment of autoimmune diseases; cellular activity, type-1\/type-2 cytokine secretion patterns and their modulation by therapeutic peptides","volume":"12","author":"Mouzaki","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.clim.2007.03.004_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0167-5699(97)80019-9","article-title":"The Th1\/Th2 paradigm","volume":"18","author":"Romagnani","year":"1997","journal-title":"Immunol. Today"},{"key":"10.1016\/j.clim.2007.03.004_bib5","first-page":"537","article-title":"Fontolizumab protein design labs","volume":"6","author":"Dumont","year":"2005","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.clim.2007.03.004_bib6","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1080\/08916930500124106","article-title":"Cytokine signal regulation and autoimmune disorders","volume":"38","author":"Nishimoto","year":"2005","journal-title":"Autoimmunity"},{"key":"10.1016\/j.clim.2007.03.004_bib7","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00002281-200405000-00009","article-title":"An update on the cytokine network in rheumatoid arthritis","volume":"16","author":"Miossec","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.clim.2007.03.004_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1023\/A:1025160614313","article-title":"Role of cytokines in the pathogenesis of autoimmune diabetes mellitus","volume":"4","author":"Rabinovitch","year":"2003","journal-title":"Rev. Endocr. Metab. Disord."},{"key":"10.1016\/j.clim.2007.03.004_bib9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1084\/jem.173.4.1029","article-title":"A recombinant human receptor antagonist to interleukin 1 improves survival after lethal endotoxemia in mice","volume":"173","author":"Alexander","year":"1991","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2007.03.004_bib10","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.4049\/jimmunol.151.3.1548","article-title":"Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists","volume":"151","author":"Mohler","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib11","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/nrd1854","article-title":"Animal models of sepsis: setting the stage","volume":"4","author":"Buras","year":"2005","journal-title":"Nat. Rev., Drug Discov."},{"issue":"suppl. 65","key":"10.1016\/j.clim.2007.03.004_bib12","first-page":"16","article-title":"The mode of action of cytokine inhibitors","author":"Arend","year":"2002","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.clim.2007.03.004_bib13","doi-asserted-by":"crossref","first-page":"205","DOI":"10.5694\/j.1326-5377.2005.tb06998.x","article-title":"Tumour necrosis factor inhibitors","volume":"18","author":"Nash","year":"2005","journal-title":"Med. J. Aust."},{"key":"10.1016\/j.clim.2007.03.004_bib14","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0264-410X(03)00196-8","article-title":"Anti-cytokine therapeutics and infections","volume":"21","author":"Dinarello","year":"2003","journal-title":"Vaccine"},{"key":"10.1016\/j.clim.2007.03.004_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/med.20042","article-title":"Small molecular anti-cytokine agents","volume":"26","author":"Wagner","year":"2006","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.clim.2007.03.004_bib16","first-page":"1","article-title":"A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA\/H mice","volume":"312","author":"Stosic-Grujicic","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.clim.2007.03.004_bib17","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1210\/en.2004-1393","article-title":"Critical role of macrophage migration inhibitory factor activity in experimental autoimmune diabetes","volume":"146","author":"Cvetkovic","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.clim.2007.03.004_bib18","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/jaut.2000.0456","article-title":"Antidiabetogenic effect of pentoxifylline is associated with systemic and target tissue modulation of cytokines and nitric oxide production","volume":"16","author":"Stosic-Grujicic","year":"2001","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2007.03.004_bib19","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1042\/0264-6021:3500717","article-title":"A new phosphospecific cell-based ELISA for p42\/p44 mitogen-activated protein kinase (MAPK), p38 MAPK, protein kinase B and cAMP-response-element-binding protein","volume":"350","author":"Versteeg","year":"2000","journal-title":"Biochem. J."},{"key":"10.1016\/j.clim.2007.03.004_bib20","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.clim.2004.05.008","article-title":"Prevention of carrageenan-induced pleurisy in mice by anti-CD30 ligand monoclonal antibody","volume":"113","author":"Di Paola","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib21","first-page":"568","article-title":"Absence of endogenous interleukin-10 enhances the evolution of murine type-II collagen-induced arthritis","volume":"12","author":"Cuzzocrea","year":"2001","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.clim.2007.03.004_bib22","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/art.20875","article-title":"Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse","volume":"52","author":"Cuzzocrea","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2007.03.004_bib23","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.171.11.6173","article-title":"Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice","volume":"171","author":"Nakae","year":"2003","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1179\/096805106X118807","article-title":"Roles for accessory molecules in microbial recognition by Toll-like receptors","volume":"12","author":"Miyake","year":"2006","journal-title":"J. Endotoxin Res."},{"key":"10.1016\/j.clim.2007.03.004_bib25","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.4049\/jimmunol.164.11.5998","article-title":"Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells","volume":"164","author":"Muzio","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib26","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.4049\/jimmunol.178.2.1164","article-title":"MyD88-dependent and MyD88-independent pathways in synergy, priming, and tolerance between TLR agonists","volume":"178","author":"Bagchi","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib27","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.2174\/138161206776873725","article-title":"Mechanisms of ERK1\/2 regulation by seven-transmembrane-domain receptors","volume":"12","author":"Werry","year":"2006","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.clim.2007.03.004_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/156802606775270323","article-title":"New approaches to the treatment of inflammatory disorders small molecule inhibitors of p38 MAP kinase","volume":"6","author":"Peifer","year":"2006","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.clim.2007.03.004_bib29","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1471-4892(03)00080-8","article-title":"Therapeutic targeting of Toll-like receptors for inflammatory and infectious diseases","volume":"3","author":"O\u2019Neill","year":"2003","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.clim.2007.03.004_bib30","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1146\/annurev.immunol.19.1.683","article-title":"Interleukin-10 and the interleukin-10 receptor","volume":"19","author":"Moore","year":"2001","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib31","doi-asserted-by":"crossref","first-page":"6853","DOI":"10.4049\/jimmunol.151.12.6853","article-title":"Predominant role of tumor necrosis factor-alpha in human monocyte IL-10 synthesis","volume":"151","author":"Wanidworanun","year":"1993","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib32","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/intimm\/7.4.517","article-title":"Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs","volume":"7","author":"Platzer","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib33","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0167-4889(96)00116-4","article-title":"Modulation of cytokine production by human mononuclear cells following impairment of Na, K-ATPase activity","volume":"1355","author":"Foey","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.clim.2007.03.004_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0896-8411(03)00044-1","article-title":"The complex role of interleukin-10 in autoimmunity","volume":"20","author":"Groux","year":"2003","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.clim.2007.03.004_bib35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1043-4666(03)00103-0","article-title":"Proinflammatory effects of exogenously administered IL-10 in experimental autoimmune orchitis","volume":"22","author":"Kaneko","year":"2003","journal-title":"Cytokine"},{"key":"10.1016\/j.clim.2007.03.004_bib36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1084\/jem.181.3.839","article-title":"Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus","volume":"181","author":"Llorente","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2007.03.004_bib37","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1006\/clin.1994.1068","article-title":"Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse","volume":"71","author":"Pennline","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.clim.2007.03.004_bib38","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1006\/cimm.2000.1658","article-title":"IL-10 deficiency does not inhibit insulitis and accelerates cyclophosphamide-induced diabetes in the nonobese diabetic mouse","volume":"202","author":"Balasa","year":"2000","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib39","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S1359-6101(03)00059-5","article-title":"Cytokine-mediated inflammation in acute lung injury","volume":"14","author":"Goodman","year":"2003","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.clim.2007.03.004_bib40","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00281-003-0127-1","article-title":"Immunopathogenesis of collagen arthritis","volume":"25","author":"Brand","year":"2003","journal-title":"Springer Semin. Immunopathol."},{"key":"10.1016\/j.clim.2007.03.004_bib41","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.4049\/jimmunol.163.9.5049","article-title":"IL-1 alpha beta blockade prevents cartilage and bone destruction in murine type II collagen-induced arthritis, whereas TNF-alpha blockade only ameliorates joint inflammation","volume":"163","author":"Joosten","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib42","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1084\/jem.177.2.547","article-title":"Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia","volume":"177","author":"Gerard","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2007.03.004_bib43","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1084\/jem.177.4.1205","article-title":"Interleukin 10 protects mice from lethal endotoxemia","volume":"177","author":"Howard","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2007.03.004_bib44","first-page":"285","article-title":"Absence of endogenous interleukin-10 enhances the evolution of acute lung injury","volume":"13","author":"Cuzzocrea","year":"2002","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.clim.2007.03.004_bib45","doi-asserted-by":"crossref","first-page":"3505","DOI":"10.4049\/jimmunol.167.6.3505","article-title":"IL-10 deficient B10.Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type II collagen antibodies","volume":"167","author":"Johansson","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2007.03.004_bib46","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1084\/jem.181.6.2289","article-title":"Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses","volume":"181","author":"Rogy","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2007.03.004_bib47","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1172\/JCI117993","article-title":"Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis","volume":"95","author":"Kasama","year":"1995","journal-title":"J. Clin. Invest."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661607000605?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661607000605?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,13]],"date-time":"2024-02-13T15:05:20Z","timestamp":1707836720000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661607000605"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["S1521661607000605"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2007.03.004","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2007,6]]}}}